Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

The Relationship Between Hypotension and Tissue O2 in Invasive Eadyn During Anesthesia Induction in Open Heart Surgery

NCT07831252 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2025-09-01
Last updated
2026-09-21

Condition(s) studied

Post-induction HypotensionEadynCerebral and Kidney Regional SaturationOpen Heart Surgery

Investigational drug(s) / intervention(s)

mostcare hemodynamic monitorMasimo NIRSHemodynamic Measurements on Standart Monitoring

mostcare hemodynamic monitor: Invasive hemodynamic variables including dynamic arterial elastance (Eadyn), stroke volume variation (SVV), pulse pressure variation (PPV), cardiac index (CI), oxygen delivery (DO₂), and cardiac power output (CPO) were obtained using the MostCare monitor.

Masimo NIRS: Cerebral and renal tissue oxygen saturation(rso2) values were measured using the Masimo device.

Hemodynamic Measurements on Standart Monitoring: Heart rate and peripheral oxygen saturation were measured using standard noninvasive monitoring.

Study summary

Our aim is to identify patients who may experience hypotension during anesthesia induction. Intraoperative hemodynamic stability plays an important role in tissue oxygenation. Although the duration of hypotension can be kept short with the necessary interventions, it is important that hypotension is predictable in order to prevent intraoperative complications and postoperative organ damage.

40 patients scheduled for open heart surgery will be monitored from one minute before anesthesia is administered until ten minutes after. Patients will be divided into two groups based on the presence or absence of hypotension during the monitoring period. All patients will be monitored according to a standardized procedure. Demographic data, non-invasive and invasive hemodynamic parameters, primarily Eadyn, and cerebral and renal tissue saturation data will be collected. Moreover, vasopressor administration in response to hypotension will be recorded.

Eligibility

Sex
ALL
Min age
18 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria: • American Society of Anaesthesiologists (ASA) Physical Status classification I to III • Patients who planned open heart surgery Exclusion Criteria: • Age \< 18 years * Presence of arrhythmia (atrial fibrillation or frequent premature beats) * Severe valvular heart disease (aortic or mitral stenosis/insufficiency) * Severe heart failure (EF \< 40%) * Congenital heart disease * Severe chronic lung disease * Chronic kidney disease requiring dialysis * Severe peripheral vascular disease * Morbid obesity * Emergency surgery cases

Primary outcome measure(s)

  • Eadyn — Perioperative
    Dynamic Arterial Elastance
  • rso2 — Perioperative
    Cerebral and Kidney Regional Saturation
  • Intraoperative hypotension — perioperative
    Explanatory outcome

Trial sites (1)

FacilityCityRegionStatus
Haseki Educational and Research Hospital Istanbul Sultangazi Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07831252 on ClinicalTrials.gov ↗ ← All trials in Turkey